Target intelligence / Profile preview

Enterobacteria phage phiX174 (phiX174)

Target
phiX174
Molecular classification
Virus, Bacteriophage, Single-stranded DNA virus, Microviridae, Other
01

Overview

Enterobacteria phage phiX174 is a small, single-stranded DNA (ssDNA) virus that specifically infects the bacterium Escherichia coli [8, 14]. It belongs to the Microviridae family and is historically significant as the first DNA-based genome to be fully sequenced, a milestone achieved by Frederick Sanger in 1977 [8, 17]. The virus replicates by hijacking the host's cellular machinery and eventually induces cell lysis through its "Protein E," which inhibits the bacterial enzyme MraY, a critical component of peptidoglycan synthesis [2, 18]. While not a therapeutic target for human disease, phiX174 is a foundational model organism in molecular biology and synthetic biology [5, 8]. It is widely used as a positive control in DNA sequencing (e.g., Illumina platforms), a tool for phage display technology, and is being researched for potential applications in phage therapy and the development of novel antibacterial agents [1, 8, 13].

Other names
ΦX174Phi X 174Microvirus phiX174Coliphage phiX174Escherichia phage phiX174
02

Mechanism of action

N/A

03

Biological functions

Viral replicationHost cell lysisDNA replicationPeptidoglycan synthesis inhibitionOther
04

Disease associations

Infection
05

Safety considerations

N/A (Not a therapeutic target)

Beyond the preview

Go deeper on Enterobacteria phage phiX174 (phiX174).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enterobacteria phage phiX174 (phiX174).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call